The toxic waste created when batteries are manufactured and disposed is a serious deterrent to widespread use of batteries compared to hydrogen fuel cells. It is a no brainier, unless you are stupid, to see that the hydrogen fuel cells have a much brighter future than batteries.
Ryan, there is nothing new in this and all of that is well known to people working in media sources. The secrecy is not causing the disappointing SP and trading of Geron shares; it's the fear of bad acquisition by the bozos at Geron and the unfair compensation package granted to Scarlett, at least prematurely. Everyone, even a fool,knows it well that Geron has a golden egg and that its future is in the hands of able hands at Janssen. What they do not like is how this acquisition thing is being handled.
And, the opt-in or opt-out matter is going to work out. Apparently, the Street do not have any confidence in the current Geron management to do it well and in the best interest of shareholders because, generally, the ma
This is a query important for someone who or a close family member suffers from MF or MDS and is not a part of the trial so far; but, for a shareholder, it is unnecessary and a worthless effort. For a shareholder, it's sufficient to know that Janssen has all the information and perhaps successfully has used it to bet the ODD, is spending formidable effort to run the trial globally and is committed to a billion- dollar contract with Geron, unless you are an oncologist/hematologist yourself. And, finally, neither this board nor Irish is the right source to get answers for!!
Two reasons in my view: 1. The bozos at Geron gave away millions of free shares to WS crooks during the last offering, which the crooks are using to manipulate SP to their advantage. 2. Scarlett deliberately prematurely announced the acquisition decision (which the WS is using for the manipulation) so that the SP is dragged down to allow him to offer a low-priced share swap to the company he is negotiating to acquire. This company most likely belongs to his acquaintance. Personally, I think he lacks adequate professional ethics as an executive and is greedy I may be wrong but so far he hasn't proven otherwise.
The contract with Janssen requires that Janssen must determine Continuation of the development work 24 months after beginning the initial MF/MDS study (I.e., by mid to late 2017) and, if it is affirmative, complete the licensing work to move to production and distribution along with marketing. The licensing rights for the IMET use for MF and MDS will be fully with Janssen and also for other applications if Geron decides to Opt-In after receiving affirmative continuation decision from Janssen. My view is that Janssen did its thorough review of the potential of IMET based on the Mayo studies and the past Geron's work before committing the billion-dollar deal; i.e., the affirmative continuation agreement is in most probability a given outcome. If so, the management's idea of acquisition of another product or an outfit means that it expects to broaden the product base instead of staying with only IMET and is not ready for merger with Janssen and retain it as an independent entity. Mt question then is: Is this management capable of running such an enlarged independent outfit? This management couldn't even handle licensing of MF and sought help from Mayo and Janssen and forced the FDA to impose a complete hold for 8 long months!! How could it do it? Is that why WS is expressing its no-confidence by dragging the SP down to its lowest since Nov 2014?!!!!
You're talking about getting off the stem-cell business and on to oncology. That is not my point! The complete hold was imposed after Scarlett came on board and supervised the mishandled ET/PV trials!! Check your dates carefully!!
The market and the bios have gone up and down; but, Geron has gone down from $5+ level to less than half of that!! I am just trying to why as I see it!!
despite no debt, a hefty cash position, and a breakthrough drug in hand! Thanks to the bozos at Geron who are busy trying to grab hefty compensation!!! Isn't it wonderful?!!!!!
Don, the fact of the matter is that despite excellent financial and asset condition, the SP has dropped fro a reasonable level of $5+ to half that much!! The only reason I can think of for that is that WS doesn't have confidence in these bozos to find a real gem for acquisition and, if they do, to handle it!! The IMET glory is brought single-handedly by Tefferi first and that the Mayo work alone could have convinced Janssen to plunge into IMET's future. Do you think these bozos who are after million dollar compensation could have done that without Tefferi and Janssen (which got the ODD for IMET so fast?!!! To me, they haven't yet proven themselves worthy of any shareholder praise!!!
Apparently not!! Simply, it helps get more contracts by facilitating financing for customers. The posts by idiots on this board questioning the need simply show the posters' ignorance or naivety w.r.t. business needs.